Recommendations for detection and rapid management of carbapenemase-producing Enterobacterales outbreaks.
Journal
Infection prevention in practice
ISSN: 2590-0889
Titre abrégé: Infect Prev Pract
Pays: England
ID NLM: 101777928
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
24
02
2020
accepted:
19
08
2020
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
10
8
2021
Statut:
epublish
Résumé
There is large heterogeneity in approaches to tackling nosocomial outbreaks caused by carbapenemase-producing Enterobacterales (CPE), however there is limited guidance on how to approach their management. Rapid and robust infection prevention and control interventions can be effective in preventing and reducing the impact of outbreaks in healthcare environments. We present a stepwise approach to aspects of CPE outbreak management, including the development of an action plan, engagement and communication with key stakeholders, developing a dynamic risk assessment, and staff education. These can provide a blueprint for organisations to create templates and checklists to inform their own outbreak response.
Identifiants
pubmed: 34368719
doi: 10.1016/j.infpip.2020.100086
pii: S2590-0889(20)30050-0
pmc: PMC8336032
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100086Informations de copyright
Crown Copyright © 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
Références
Interdiscip Perspect Infect Dis. 2013;2013:582831
pubmed: 24489540
Infect Control Hosp Epidemiol. 2020 Jan;41(1):37-43
pubmed: 31637986
Infect Control Hosp Epidemiol. 2011 Nov;32(11):1103-8
pubmed: 22011538
J Hosp Infect. 2016 Jan;92(1):73-7
pubmed: 26542949
J Hosp Infect. 2019 May;102(1):63-69
pubmed: 30571992
J Hosp Infect. 2015 Nov;91(3):211-7
pubmed: 26365827
Clin Microbiol Infect. 2017 Dec;23(12):961-967
pubmed: 28412380
Crit Care. 2012 Jul 31;16(4):142
pubmed: 22849650
Am J Infect Control. 2011 Sep;39(7):555-9
pubmed: 21864762
Nurs Times. 2011 Jan 18-24;107(2):22-5
pubmed: 21366010
Infect Control Hosp Epidemiol. 2013 Jan;34(1):56-61
pubmed: 23221193
J Hosp Infect. 2019 Aug;102(4):377-393
pubmed: 30794854
BMJ Open. 2018 Apr 24;8(4):e016367
pubmed: 29691240
Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1615-20
pubmed: 25957988
J Antimicrob Chemother. 2014 Jul;69(7):1972-80
pubmed: 24710025
Antimicrob Agents Chemother. 2015 Jan;59(1):714-6
pubmed: 25348541
J Hosp Infect. 2015 Aug;90(4):285-92
pubmed: 25935701
Infect Control Hosp Epidemiol. 2008 Nov;29(11):1035-41
pubmed: 18851687
Lancet Infect Dis. 2015 Feb;15(2):212-24
pubmed: 25467650
Ann Intern Med. 2013 Mar 5;158(5 Pt 2):404-9
pubmed: 23460097
Antimicrob Resist Infect Control. 2019 Feb 13;8:37
pubmed: 30809380
Clin Microbiol Infect. 2011 Aug;17(8):1201-8
pubmed: 21054665
PLoS One. 2019 Mar 28;14(3):e0214327
pubmed: 30921364
BMC Health Serv Res. 2019 Oct 12;19(1):689
pubmed: 31606053
Antimicrob Resist Infect Control. 2017 Feb 16;6:24
pubmed: 28239453
J Med Microbiol. 2012 Aug;61(Pt 8):1052-1061
pubmed: 22683659
Clin Microbiol Infect. 2019 Jul;25(7):807-817
pubmed: 30708122
Clin Infect Dis. 2013 Dec;57(11):1593-9
pubmed: 23934166
Clin Infect Dis. 2017 May 15;64(suppl_2):S51-S60
pubmed: 28475791
J Hosp Infect. 2015 Jul;90(3):186-95
pubmed: 25986165
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
J Hosp Infect. 2010 Jun;75(2):137-8
pubmed: 20299132
Ther Adv Infect Dis. 2014 Jun;2(3-4):79-90
pubmed: 25469234